Evercore ISI Group Upgrades Bionomics to Outperform, Announces $6 Price Target
Evercore ISI Group analyst Joshua Schimmer upgrades Bionomics (NASDAQ:BNOX) from In-Line to Outperform and announces $6 price target.
Jefferies Upgrades Roblox to Buy, Raises Price Target to $48
Jefferies analyst Andrew Uerkwitz upgrades Roblox (NYSE:RBLX) from Hold to Buy and raises the price target from $30 to $48.
Piper Sandler Upgrades KeyCorp to Neutral, Lowers Price Target to $16.5
Piper Sandler analyst Scott Siefers upgrades KeyCorp (NYSE:KEY) from Underweight to Neutral and lowers the price target from $18.5 to $16.5.
Baird Upgrades KeyCorp to Outperform, Announces $20 Price Target
Baird analyst David George upgrades KeyCorp (NYSE:KEY) from Neutral to Outperform and announces $20 price target.
Citigroup Upgrades Silk Road Medical to Neutral
Citigroup analyst Joanne Wuensch upgrades Silk Road Medical (NASDAQ:SILK) from Sell to Neutral.
Barclays Upgrades United Airlines Holdings to Overweight, Raises Price Target to $80
Barclays analyst Brandon Oglenski upgrades United Airlines Holdings (NASDAQ:UAL) from Equal-Weight to Overweight and raises the price target from $52 to $80.
Piper Sandler Upgrades Zimmer Biomet Holdings to Overweight
Piper Sandler analyst Matt O'Brien upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Neutral to Overweight.
Piper Sandler Upgrades Riskified to Overweight, Raises Price Target to $8
Piper Sandler analyst Brent Bracelin upgrades Riskified (NYSE:RSKD) from Neutral to Overweight and raises the price target from $6 to $8.
Analysts Cheer Nuvei Post Upbeat Q4; 20%+ Ex-Crypto Organic Growth Validates Its Moats And Market Share Gains
Credit Suisse analyst Timothy Chiodo upgrades Nuvei Corp (NASDAQ:NVEI) from Neutral to Outperform and raises the price target from $37 to $45.…
Sidoti & Co. Upgrades HNI to Buy, Announces $34 Price Target
Sidoti & Co. analyst Gregory Burns upgrades HNI (NYSE:HNI) from Neutral to Buy and announces $34 price target.